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Genomic damage plays an important role in cancer onset
and progression. But how exactly do mutations, copy
number changes, and epigenetic events affect the wiring of
otherwise normal-functioning cellular pathways? Genomic
probing with technologies such as RNA sequencing, copy
number profiling, and DNA promoter methylation arrays
are providing unprecedented views of cells. Uncovering
predictive models from these datasets to shed light on key
disrupted pathways in cancer is a major challenge that
could offer breakthroughs for personalized medicine.
I’ll describe a new pathway-based strategy that gives
novel insight into the functional impact of mutations in
particular genes. The major mechanism by which cancer
arises is through somatic mutations. Individual tumors
can contain hundreds to thousands of mutations. It is cri-
tical to distinguish mutations that have an important role
defining the cancer - driver mutations - from mutations
that are unimportant to the tumor - passenger mutations.
A pathway-based approach is able to detect a shift in the
downstream effects of an altered gene compared to what
is expected from its upstream regulatory input. Applica-
tion to several datasets across multiple tissues revealed
several important driver mutations even among rarely
mutated genes. Thus, pathway analysis shows promise in
differentiating driver and passenger events that will
increase our understanding of cancer disease mechanisms,
which can help identify novel targets for treatment.
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